Heart failure therapy in evolution.
Chatterjee
K
K
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D002227:Carbazoles / Q000627:therapeutic use; D002303:Cardiac Output, Low / Q000401:mortality / Q000503:physiopathology / Q000628:therapy*; D002309:Cardiology / Q000639:trends*; D000077261:Carvedilol; D004656:Enalapril / Q000627:therapeutic use; D005080:Exercise Test; D006801:Humans; D009026:Mortality; D011412:Propanolamines / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D002227:Carbazoles; D011412:Propanolamines; D000077261:Carvedilol; D004656:Enalapril